APA (7th ed.) Citation

C, G., WW, F., SM, L., AW, Y., DC, C., FTH, W., . . . C, K. (2026). mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.02.27.708377

Chicago Style (17th ed.) Citation

C, Gentile, et al. "MSWI/SNF Complex Inhibition Sensitizes KRAS-mutant Lung Cancers to Targeted Therapies via Epithelial-mesenchymal Subversion." BioRxiv : The Preprint Server for Biology 2026. https://doi.org/10.64898/2026.02.27.708377.

MLA (9th ed.) Citation

C, Gentile, et al. "MSWI/SNF Complex Inhibition Sensitizes KRAS-mutant Lung Cancers to Targeted Therapies via Epithelial-mesenchymal Subversion." BioRxiv : The Preprint Server for Biology, 2026, https://doi.org/10.64898/2026.02.27.708377.